#news #biotech Denali, Odonate seek $273M Nasdaq IPOs

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Denali, Odonate seek $273M Nasdaq IPOs .The heavily-backed neurodegenerative diseases Denali Therapeutics and oral chemo biotech Odonate Therapeutics are looking to make hay while the sun shines by filing for two big IPOs.

from FierceBiotech: Biotech http://ift.tt/2zBzFlS